Rene Russo (Alicia Petitti for Xilio)

Ex ni­hi­lo: Take­da leads $100M+ round to fund biotech's sneak at­tack on tu­mors, pro­pelling new IL-2, CT­LA-4 drugs to clin­ic

Since emerg­ing out of stealth in 2018 with $30 mil­lion in launch mon­ey from At­las and F-Prime, Akre­via has kept a rel­a­tive­ly low pro­file …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.